NEISVAC-C
Google image searchProduct monograph
Active ingredients
meningococcal polysaccharide vaccine grp c, 10 MCG/0.5 ML
tetanus toxoid, 20 MCG/0.5 ML
DIN: 02245057
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: PFIZER CANADA ULC
Date: 03-DEC-2015
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AH — Meningococcal vaccines (ATC, ATC/DDD)
- J07AH07 — MENINGOCOCCUS C, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED (ATC/DDD)
Reference brand drug: Neisvac-c
